AFFLUENT MEDICAL SAS EO 1
Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. The company offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well … Read more
AFFLUENT MEDICAL SAS EO 1 (0JZ) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, AFFLUENT MEDICAL SAS EO 1 (0JZ) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
AFFLUENT MEDICAL SAS EO 1 - Net Assets Trend (None–None)
This chart illustrates how AFFLUENT MEDICAL SAS EO 1's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for AFFLUENT MEDICAL SAS EO 1 (None–None)
The table below shows the annual net assets of AFFLUENT MEDICAL SAS EO 1 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to AFFLUENT MEDICAL SAS EO 1's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
AFFLUENT MEDICAL SAS EO 1 Competitors by Market Cap
The table below lists competitors of AFFLUENT MEDICAL SAS EO 1 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Camil Alimentos S.A
SA:CAML3
|
$30.31 Million |
|
AleAnna, Inc. Class A Common Stock
NASDAQ:ANNA
|
$30.32 Million |
|
DE&T Co. Ltd
KQ:079810
|
$30.32 Million |
|
BeWhere Holdings Inc
OTCQB:BEWFF
|
$30.33 Million |
|
RetinalGenix Technologies Inc
OTCQB:RTGN
|
$30.27 Million |
|
Bellavista Resources Ltd
AU:BVR
|
$30.26 Million |
|
Tune Protect Group Bhd
KLSE:5230
|
$30.25 Million |
|
Sandfire Resources America Inc
OTCQB:SRAFF
|
$30.24 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AFFLUENT MEDICAL SAS EO 1's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares AFFLUENT MEDICAL SAS EO 1's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently AFFLUENT MEDICAL SAS EO 1 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares AFFLUENT MEDICAL SAS EO 1's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AFFLUENT MEDICAL SAS EO 1 (0JZ) | €- | N/A | N/A | $30.29 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |